| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $44.8M | -20.6% |
| SG&A Expense | $15.8M | -16.8% |
| Operating Income | -$60.7M | +17.6% |
| Interest Expense | $5.3M | +59.3% |
| Income Tax | $0 | — |
| Net Income | -$60.8M | +13.7% |
| EPS (Basic) | -$1.32 | +19.0% |
| EPS (Diluted) | -$1.33 | +18.4% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $57.0M | -48.6% |
| Current Assets | $58.6M | -48.2% |
| Total Assets | $69.4M | -45.3% |
| Current Liabilities | $36.1M | +138.1% |
| Long-term Debt | $32.1M | +0.0% |
| Total Liabilities | $44.6M | -16.7% |
| Stockholders' Equity | $24.8M | -66.2% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$60.3M | -7.3% |
| Capital Expenditures | $0 | -100.0% |
| Investing Cash Flow | $0 | +100.0% |
| Financing Cash Flow | $6.0M | -53.9% |
| Free Cash Flow | -$60.3M | -6.8% |